A biostatistician and statistical programmer, Noel has experience designing clinical trials while ensuring that processes within these functional areas are compliant with ICH guidelines. In more than 12 years of clinical research work, Noel has gained significant therapeutic area experience in Alzheimer’s, Cushing’s, Parkinson's, ALS, and phase 1 clinical pharmacology trials. Her areas of expertise include sample size calculations, randomization schedules, writing and executing statistical analysis plans, running and validating analyses, developing ad hoc analyses, writing statistical reports, and preparing manuscripts for publication, as well as such specialties as PK/EKG safety summary and reporting, drug liking/abuse potential studies, and longitudinal analysis of dental caries and dentures.

Noel has authored statistical analysis plans, programmed datasets to CDISC standards, generated TLFs, and everything in between. Her work in neurodegenerative diseases in collaboration with pharmaceutical companies, academic groups, and non-profit organizations has resulted in 38 publications. Noel has also provided biostatistics oversight for other CROs.

Noel graduated Magna Cum Laude from Brigham Young University with a bachelor’s degree in biostatistics and a master’s degree in statistics. She currently is pursuing a PhD in Computing with an Emphasis in Data Science at Boise State University, completing coursework in artificial intelligence, natural language processing, and machine learning.

Noel provides strategic leadership and subject matter expertise as Trialwise’s Director of Biostatistics.

Director of Biostatistics

Noel Ellison